Filter By
Search
-
INTEGRAGEN AND BIOASTER SIGN PARTNERSHIP AGREEMENT IN GENOMICS AND TRANSCRIPTOMICS
IntegraGen and BIOASTER have been collaborating for several years on genomic and transcriptomic analyses. Driven by...
-
INTEGRAGEN SUPPORTS THE ANTOINE LACASSAGNE CENTER IN NICE FOR A LARGE-SCALE RESEARCH PROJECT ON COLORECTAL CANCER PATIENTS
Founded in 1961, the Centre Antoine Lacassagne is one of 18 cancer centers...
-
NEW LOOK. NEW PORTFOLIO. NEW OPPORTUNITIES.
FOLLOWING ITS ACQUISITION BY ONCODNA, INTEGRAGEN HAS UNDERGONE A COMPLETE OVERHAUL AND IS NOW...
-
POTENTIAL INVOLVEMENT OF URINARY TRACT INFECTIONS IN THE DEVELOPMENT OF BLADDER CANCER
Uropathogenic E.coli induces DNA damage in the bladder As provider of the whole genome sequencing, IntegraGen...
-
NEW PERSPECTIVES IN THE DIAGNOSIS AND TREATMENT OF DUCHENNE MUSCULAR DYSTROPHY
Myogenesis modelled by human pluripotent stem cells: a multi-omic study of Duchenne myopathy early onset...
-
BRIEF TECHNIQUE: LOW-PASS WHOLE GENOME SEQUENCING - GETTING MORE FROM LESS
LP-WGS analysis of liquid biopsies (ctDNA) for oncology applications Background Analysis of circulating tumor DNA...
-
-
INTEGRAGEN ACHIEVES CE MARKING FOR MERCURY™, A CLOUD-BASED SOFTWARE APPLICATION FOR INTERPRETING MOLECULAR DATA FROM CANCER PATIENTS' TUMORS
IntegraGen announces the CE marking of its cloud-hosted online software application,...
-
INTEGRAGEN UPDATE - ALWAYS OPEN FOR YOUR PROJECTS
IntegraGen is following government recommendations and precautionary measures related to the...
-
COVID-19: MEASURES TO PROTECT EVERYONE AND ENSURE YOUR PROJECTS RUN SMOOTHLY
Dear IntegraGen customers and partners, We care about your satisfaction and understand that all...
